Jim Wassil - 31 Aug 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: CHIEF OPERATING OFFICER
Issuer ticker: PCVX
Reported as of: 31 Aug 2026
Net transaction value: -$212,352
SEC form: 4
Accepted by SEC: 02 Sep 2026, 19:58:39 UTC
Prior SEC filing: 05 Aug 2026
Next SEC filing: 09 Sep 2026
Source filing: View source filing
Reporting owner signature: Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact

Key filing fact

Jim Wassil filed Form 4 for Vaxcyte, Inc. (PCVX) on 02 Sep 2026.

Key facts

This page summarizes Jim Wassil's Form 4 filing for Vaxcyte, Inc. (PCVX).
8 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Sep 2026, 19:58.

Change

Previous filing in this sequence was filed on 05 Aug 2026.
Current net transaction value: -$212,352.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001813798 Primary reporting owner

Wassil Jim

Relationship: CHIEF OPERATING OFFICER
Address: C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS
Signature: Jim Wassil, by /s/ Peter N. Efremenko, Attorney-In-Fact
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Tax liability

Transaction value
Shares: -1,273
Change %: -0.81%
Price: $60.74^*
Shares after: 156,268
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1

PCVX transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,250
Change %: +1.4%
Price: $5.35^*
Shares after: 158,518
Date: 01 Sep 2026
Ownership: Direct

PCVX transaction

Common Stock

Sale

Transaction value: $93,582
Shares: -1,537
Change %: -0.97%
Price: $60.89
Shares after: 156,981
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2, F3

PCVX transaction

Common Stock

Sale

Transaction value: $43,836
Shares: -713
Change %: -0.45%
Price: $61.48
Shares after: 156,268
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2, F4

PCVX transaction

Common Stock

Sale

Transaction value: $56,322
Shares: -924
Change %: -0.59%
Price: $60.96
Shares after: 155,344
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2, F5

PCVX transaction

Common Stock

Sale

Transaction value: $18,611
Shares: -303
Change %: -0.2%
Price: $61.42
Shares after: 155,041
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F2, F6

PCVX transaction

Common Stock

Tax liability

Transaction value
Shares: -1,432
Change %: -0.92%
Price: $61.58^*
Shares after: 153,609
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -2,250
Change %: -3.3%
Price: $0.000000^*
Shares after: 66,648
Date: 01 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,250
Exercise price: $5.35
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.

Footnote F2

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.

Footnote F3

The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F4

The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F5

The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F6

The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F7

Stock Option is fully vested and exercisable.